[1] |
COHEN-ROSENBLUM A, CUI Q. Osteonecrosis of the Femoral Head[J]. Orthop Clin North Am, 2019, 50(2):139-149.
DOI
URL
|
[2] |
孔芳, 李小霞, 赵义. 系统性红斑狼疮并发股骨头坏死或膝关节骨梗死的临床特点分析[J]. 中国医师杂志, 2020, 22(5):766-770.
|
[3] |
DORE R, KROTENKO R, REISING J P, et al. Nesfatin-1 decreases the motivational and rewarding value of food[J]. Neuropsychopharmacology, 2020, 45(10):1645-1655.
DOI
URL
|
[4] |
YIN Y, DING L, HOU Y, et al. Upregulating microRNA-410 or downregulating Wnt-11 increases osteoblasts and reduces osteoclasts to alleviate osteonecrosis of the femoral head[J]. Nanoscale Res Lett, 2019, 14(1):383.
DOI
URL
|
[5] |
REINHOLD S, BLANKESTEIJN W M. Wnt/β-catenin inhibitor Dickkopf 1[J]. Arterioscler Thromb Vasc Biol, 2019, 39(2):121-123.
DOI
URL
|
[6] |
CHOI H R, STEINBERG M E, Y CHENG E. Osteonecrosis of the femoral head:diagnosis and classification systems[J]. Curr Rev Musculoskelet Med, 2015, 8(3):210-220.
DOI
URL
|
[7] |
中国医师协会骨科医师分会显微修复工作委员会, 中国修复重建外科专业委员会骨缺损及骨坏死学组, 中华医学会骨科分会显微修复学组. 成人股骨头坏死临床诊疗指南(2016)[J]. 中华骨科杂志, 2016, 36(15):945-954.
|
[8] |
杨娟, 徐瑾. 绝经后骨质疏松症患者血清铁调素水平变化及临床意义[J]. 检验医学, 2019, 34(1):23-27.
|
[9] |
ZHANG Q Y, LI Z R, GAO F Q, et al. Pericollapse stage of osteonecrosis of the femoral head:a last chance for joint preservation[J]. Chin Med J(Engl), 2018, 131(21):2589-2598.
|
[10] |
SCHALLA M A, STENGEL A. Current understanding of the role of Nesfatin-1[J]. J Endocr Soc, 2018, 2(10):1188-1206.
DOI
URL
|
[11] |
邓润钧. Nesfatin-1的研究进展[J]. 胃肠病学, 2014, 19(6):371-373.
|
[12] |
KVLIVIDZE T Z, ZAVODOVSKY B V, AKHVERDYAN Y R, et al. Serum nesfatin-1 as a marker of systemic inflammation in rheumatoid arthritis[J]. Klin Lab Diagn, 2019, 64(1):53-56.
DOI
URL
|
[13] |
PUZIO I, TYMICKI G, PAWOWSKA M, et al. Nesfatin-1 prevents negative changes in bone in conditions of developing osteopenia[J]. Ann Agric Environ Med, 2020, 27(1):66-75.
DOI
URL
|
[14] |
ZHANG Y, SHUI X, LIAN X, et al. Serum and synovial fluid nesfatin-1 concentration is associated with radiographic severity of knee osteoarthritis[J]. Med Sci Monit, 2015, 21:1078-1082.
DOI
URL
|
[15] |
JIANG L, BAO J, ZHOU X, et al. Increased serum levels and chondrocyte expression of nesfatin-1 in patients with osteoarthritis and its relation with BMI,hsCRP,and IL-18[J]. Mediators Inflamm, 2013, 2013:631251.
|
[16] |
DAOUSSIS D, PAPACHRISTOU D J, DIMITROULAS T, et al. Dickkopf-1 is downregulated early and universally in the skin of patients with systemic sclerosis despite normal circulating levels[J]. Clin Exp Rheumatol, 2018, 113(4):45-49.
|
[17] |
LI J, GONG W, LI X, et al. Recent progress of Wnt pathway inhibitor Dickkopf-1 in liver cancer[J]. J Nanosci Nanotechnol, 2018, 18(8):5192-5206.
DOI
URL
|
[18] |
RUARO B, CASABELLA A, PAOLINO S, et al. Dickkopf-1(Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients:correlation with the Trabecular Bone Score(TBS)[J]. Clin Rheumatol, 2018, 37(11):3057-3062.
DOI
URL
|
[19] |
KLAVDIANOU K, LIOSSIS S N, SAKKAS L, et al. The role of Dickkopf-1 in joint remodeling and fibrosis:a link connecting spondyloarthropathies and scleroderma?[J]. Semin Arthritis Rheum, 2017, 46(4):430-438.
DOI
URL
|
[20] |
KO J Y, WANG F S, WANG C J, et al. Increased Dickkopf-1 expression accelerates bone cell apoptosis in femoral head osteonecrosis[J]. Bone, 2010, 46(3):584-591.
DOI
URL
|
[21] |
岳辰, 张雪, 温阳阳, 等. siRNA慢病毒载体介导DKK-1 基因沉默对骨髓间充质干细胞分化影响的实验研究[J]. 中华骨与关节外科杂志, 2018, 11(2):137-142.
|